↓ Skip to main content

Dove Medical Press

Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
Title
Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
Published in
ClinicoEconomics and Outcomes Research: CEOR, March 2023
DOI 10.2147/ceor.s389456
Pubmed ID
Authors

Lauren Ramjee, Nesrin Vurgun, Christopher Ngai, Mit Patel, Gabriel Tremblay

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 20%
Unspecified 1 10%
Student > Ph. D. Student 1 10%
Lecturer > Senior Lecturer 1 10%
Unknown 5 50%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Linguistics 1 10%
Unspecified 1 10%
Neuroscience 1 10%
Nursing and Health Professions 1 10%
Other 0 0%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2024.
All research outputs
#3,884,542
of 25,898,387 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#90
of 527 outputs
Outputs of similar age
#74,642
of 426,903 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#2
of 10 outputs
Altmetric has tracked 25,898,387 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,903 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.